Register by September 17 and Save up to $350!
Molecular advances in biomedical science require high-quality biospecimens (tissue, body fluid, or other material) which provide macromolecules (DNA/RNA, proteins, enzymes, etc.) that are used for diagnostic, therapeutic, and epidemiologic purposes, allowing researchers to better link molecular and clinical information. Today, biospecimen collections are used by multiple groups for varying aims from basic research through clinical trials. Investigators realize that the proper collection, processing, storage, and tracking of biospecimens are critical components of biomarker-related studies.
Thus, by necessity, biobanking is both a science and a business; therefore, BioBanking: Maximizing Your Investment focuses on both angles.
|
As biobank repositories grow, the pressure increases for standardization, documentation, protocols, and preservation procedures to efficiently produce the best quality product. In addition, “omics” has complicated the direction of biomedical research, and those managers involved must now negotiate the regulatory, ethical, and legal issues involved in the preservation and use of biospecimens.
Who Should Attend:
Directors, heads, and managers of:
Biobanks Tissue banks Biorepositories
Pathologists
Click here to download brochure
|
Recent advances in molecular high-throughput assays have intensified the need for well annotated, properly preserved biospecimens. A thorough assay often requires samples from both diseased/treated and normal/untreated tissue. The Science of BioBanking addresses methodologies that maximize the quality and utility of biospecimens for biomarker research.
Who Should Attend:
Research scientists working with:
Biospecimens Biomarkers Bioextraction Biopreservation
Click here to download brochure
|